Aifred uses AI to accomplish what was previously not possible with other methods: helping clinicians and patients make better choices when presented with a large number of treatments that are all similarly effective at the population level, but not at the individual patient and treatment level.
Along with a network of domain experts in psychiatry, we are harnessing the power of AI to better understand patterns in patient data that can predict optimal treatment, without reliance on biomarker inputs.
Having started in major depression, Aifred plans to encompass a broad spectrum of mental health conditions, leveraging its treatment-agnostic AI platform. At its core, Aifred is focused on bringing better mental healthcare to all.
In 2021, Aifred placed #1 in North America and #2 in the World in the Global IBM Watson AI XPRIZE with its AI model for personalized treatment response prediction in major depression. In 2024 Aifred received Health Canada approval for its platform and has submitted for FDA approval in 2025.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 1600 Rue Notre-Dame O, 304,canada
- in****@****lth.com
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- aifredhealth.com
- Keywords
- Montreal.
- HQ
- Montreal, Quebec
Aifred Health Questions
Aifred Health's website is aifredhealth.com
Aifred Health's LinkedIn profile is https://ca.linkedin.com/company/aifred
Aifred Health has
17 employees.
View email and phone details for 17
employees at Aifred Health.
Aifred Health's industry is
Software Development
Aifred Health's top competitors are
Alfred Health,
Biotwin,
Alayacare,
Nurau,
Crim,
Afx Medical,
Influitive,
Therappx,
Findspace,
Dialogue.
Aifred Health's support email address is info@aifredhealth.com
Aifred Health's categories are Software Development
Aifred Health's founding year is 2017
